| Identification | Back Directory | [Name]
N-hydroxy-4-((5-(4-(5-isopropyl-2-methylthiazol-4-yl)phenoxy)pentyl)oxy)benzimidamide(WXG01597) | [CAS]
491577-61-8 | [Synonyms]
DW-1350
N-hydroxy-4-((5-(4-(5-isopropyl-2-methylthiazol-4-yl)phenoxy)pentyl)oxy)benzimidamide
N-hydroxy-4-((5-(4-(5-isopropyl-2-methylthiazol-4-yl)phenoxy)pentyl)oxy)benzimidamide(WXG01597)
Benzenecarboximidamide, N-hydroxy-4-[[5-[4-[2-methyl-5-(1-methylethyl)-4-thiazolyl]phenoxy]pentyl]oxy]- | [Molecular Formula]
C25H31N3O3S | [MDL Number]
MFCD18633210 | [MOL File]
491577-61-8.mol | [Molecular Weight]
453.6 |
| Hazard Information | Back Directory | [Uses]
DW-1350 is a LTB4 receptor antagonist. | [IC 50]
LTB4 | [storage]
Store at -20°C | [References]
[1] Kang JH, et al. 5-Lipoxygenase inhibitors suppress RANKL-induced osteoclast formation via NFATc1expression. Bioorg Med Chem. 2015 Nov 1;23(21):7069-78. DOI:10.1016/j.bmc.2015.09.025 |
|
| Company Name: |
Wuxi AppTec
|
| Tel: |
022-59987777 13552403979 |
| Website: |
www.labnetwork.com |
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|